Members, on a voluntary basis, are from:

  • Academia (i.e. clinicians and researchers)
  • Advocacy (i.e. parents, patients and survivors)
  • Industry, including clinicians, researchers and representatives from regulatory affairs
  • Regulatory bodies, such as the European Medicine Agency and the Paediatric Committee, the Food and Drug Administration and national Competent Authorities.
  • Any other stakeholders with interest in paediatric oncology drug development

Some of our members (see below):



For more information, please contact
You can tweet using #ACCELERATEplatform